Multi-peptide Vaccine With Basilixumab for Breast Cancer
Clinical trial NCT01660529 · COMPLETED
Trial details
- NCT number
- NCT01660529
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-11-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.